BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 16190565)

  • 1. [Hepatitis C infections in dialyzed patients].
    Podlasin RB
    Przegl Epidemiol; 2005; 59(2):541-7. PubMed ID: 16190565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of hepatitis C in patients on renal replacement therapy].
    Tornai I; Mátyus J
    Orv Hetil; 2007 Mar; 148(11):489-94. PubMed ID: 17350920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Management of hepatitis B virus and hepatitis C virus infection in chronic kidney failure].
    Vallet-Pichard A; Pol S
    Nephrol Ther; 2015 Nov; 11(6):507-20. PubMed ID: 26423779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of hepatitis C in HIV infected and other immunocompromised individuals.
    Seth AK
    Trop Gastroenterol; 2006; 27(3):111-7. PubMed ID: 17310553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of hepatitis C virus infection in patients with end-stage renal disease.
    Liu CH; Kao JH
    J Gastroenterol Hepatol; 2011 Feb; 26(2):228-39. PubMed ID: 21261711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of hepatitis C virus infection (HCV) after renal transplantation: implications for HCV-positive dialysis patients awaiting a kidney transplant.
    Kamar N; Ribes D; Izopet J; Rostaing L
    Transplantation; 2006 Oct; 82(7):853-6. PubMed ID: 17038897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of hepatitis C in hemodialysis patients with pegylated interferon alpha-2a as monotherapy.
    Sikole A; Dzekova P; Selja N; Gaseva M; Nikolov IG; Zabzun M; Muharemi S; Asani A; Amitov V; Mena S; Grunevska V; Ivanovski L; Polenakovic M
    Ren Fail; 2007; 29(8):961-6. PubMed ID: 18067041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment in chronic renal failure].
    Curciarello J; Fernández JL; Silva M
    Acta Gastroenterol Latinoam; 2005 Jun; 35 Suppl 1():S55-7. PubMed ID: 20214305
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of chronic hepatitis C in hemodialysis patients.
    Berenguer M
    Hepatology; 2008 Nov; 48(5):1690-9. PubMed ID: 18972442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HCV infection in the setting of HIV: prevalence, disease, treatment.
    Laurence J
    AIDS Read; 2006 Mar; 16(3):115-6. PubMed ID: 16538952
    [No Abstract]   [Full Text] [Related]  

  • 11. [Efficacy and safety of pegylated-interferon plus ribavirin in HIV-infected patients co-infected with hepatitis C virus in clinical practice: a 32 cases observational follow-up].
    Seydi M; Morlat P; Bonnet F; Rambeloarisoa J; Bernard N; Lacoste D; Bonarek M; Trimoulet P; Ramanampamonjy R; Lafon ME; Dramé M; Beylot J
    Rev Med Interne; 2005 Apr; 26(4):280-7. PubMed ID: 15820563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C infection and the patient with end-stage renal disease.
    Fabrizi F; Poordad FF; Martin P
    Hepatology; 2002 Jul; 36(1):3-10. PubMed ID: 12085342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early antiviral treatment of hepatitis C virus recurrence after liver transplantation in HIV-infected patients.
    Castells L; Esteban JI; Bilbao I; Vargas V; Allende H; Ribera E; Piron M; Sauleda S; Len O; Pahissa A; Esteban R; Guardia J; Margarit C
    Antivir Ther; 2006; 11(8):1061-70. PubMed ID: 17302376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C virus infection in haemodialysis and kidney transplant patients.
    Baid-Agrawal S; Pascual M; Moradpour D; Frei U; Tolkoff-Rubin N
    Rev Med Virol; 2008; 18(2):97-115. PubMed ID: 18064722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined treatment with pegylated interferon (alpha-2b) and ribavirin in the acute phase of hepatitis C virus recurrence after liver transplantation.
    Castells L; Vargas V; Allende H; Bilbao I; Luis Lázaro J; Margarit C; Esteban R; Guardia J
    J Hepatol; 2005 Jul; 43(1):53-9. PubMed ID: 15876467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New approaches to the treatment of hepatitis C virus infection after liver transplantation using ribavirin.
    Bizollon T; Ducerf C; Trépo C
    J Hepatol; 1995; 23 Suppl 2():22-5. PubMed ID: 8720290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and histological efficacy of pegylated interferon and ribavirin therapy of recurrent hepatitis C after liver transplantation.
    Fernández I; Meneu JC; Colina F; García I; Muñoz R; Castellano G; Fuertes A; Abradelo M; Lumbreras C; Moreno E; Solís-Herruzo JA
    Liver Transpl; 2006 Dec; 12(12):1805-12. PubMed ID: 17133585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of hepatitis C infection among patients with renal failure.
    Latt NL; Araz F; Alachkar N; Durand CM; Gurakar A
    Minerva Gastroenterol Dietol; 2015 Mar; 61(1):39-49. PubMed ID: 25390288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis C virus infection in end-stage renal disease and kidney transplantation.
    Burra P; Rodríguez-Castro KI; Marchini F; Bonfante L; Furian L; Ferrarese A; Zanetto A; Germani G; Russo FP; Senzolo M
    Transpl Int; 2014 Sep; 27(9):877-91. PubMed ID: 24853721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis C infection associated with renal disease and chronic renal failure.
    Poordad FF; Fabrizi F; Martin P
    Semin Liver Dis; 2004; 24 Suppl 2():69-77. PubMed ID: 15346249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.